Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare clinical, economical and quality of life (QOL)
outcomes in patients living with HIV on zidovudine/stavudine regimen and tenofovir regimen.
This study will be an unblinded randomized trial. The first step will be empirical data
collection for one year for calculating the incremental cost effectiveness ratio (ICER). The
second step will be to perform a simulation model for calculating long term ICER.